Latest Regulatory News

Bayan Mining and Minerals Limited has verified key rare earth element minerals at its Desert Star project in California, confirming a phosphate-rich hard-rock system dominated by light rare earth elements. The company is advancing towards its maiden drill program following regulatory approvals.

Condor Energy has agreed to acquire Jaguar Exploration’s 20% stake in the TEA 86 offshore Peru project, moving to full ownership. The deal, structured through performance shares, aims to simplify equity and support licence conversion and future partnerships.

Electro Optic Systems Holdings Limited (ASX: EOS) has concluded its civil penalty proceedings with ASIC, agreeing to a $4 million penalty and costs. This resolution marks a significant step in addressing legacy issues and refocusing on strategic growth.

De.mem Limited has responded to an ASX query regarding the late lodgement of an Appendix 3Y for director Andreas Hendrik De Wit, attributing the delay to an administrative oversight. The company has outlined existing compliance protocols and introduced additional measures to prevent future lapses.

Identitii Limited has secured $200,000 through a placement of approximately 28.57 million shares at $0.007 each to existing shareholders, including Cameron Beavis, to address short-term funding needs while adhering to Takeovers Panel orders related to its Rights Issue.

Mesoblast Limited (ASX:MSB, Nasdaq:MESO) has received FDA Investigational New Drug clearance to initiate a pivotal clinical trial of its cell therapy Ryoncil in children with Duchenne Muscular Dystrophy, aiming to address inflammation-driven disease progression.

Insignia Financial has received Foreign Investment Review Board approval for its proposed acquisition by Daintree BidCo, clearing a key regulatory hurdle. The scheme now awaits shareholder and court approvals, with the board recommending shareholder support.

Tamboran Resources Corporation has initiated a significant equity raise totaling approximately US$198 million to fund expanded drilling and development activities in the Beetaloo Basin. The capital raise includes a registered underwritten public offering and a pro rata entitlement offer, representing a 25% increase in shares on issue.

Tamboran Resources Corporation has initiated an underwritten public offering of nearly 3 million shares to support expanded drilling and resource delineation in the Beetaloo Basin, alongside a concurrent institutional entitlement offer.

Multistack International Limited (ASX:MSI) has agreed in principle to sell all its assets and liabilities to Hong Kong-based Willing Y Limited, marking a significant strategic shift as MSI plans to discontinue its current business and explore new opportunities.

Rent.com.au Limited has clarified the timing and materiality of its recent Senior Debt Facility increase and extension, responding to an ASX query. The company also addressed insider trading compliance related to director share purchases in March 2026.

Neuren Pharmaceuticals’ partner Acadia Pharmaceuticals has broadened availability of DAYBUE STIX, a new FDA-approved powder formulation of trofinetide for Rett syndrome, in the US. Early caregiver feedback and expert consensus highlight its potential role in personalised patient care.